373 related articles for article (PubMed ID: 15150380)
1. Risk factors for community-acquired ciprofloxacin-resistant Escherichia coli urinary tract infection.
Killgore KM; March KL; Guglielmo BJ
Ann Pharmacother; 2004; 38(7-8):1148-52. PubMed ID: 15150380
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
Arslan H; Azap OK; Ergönül O; Timurkaynak F;
J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
[TBL] [Abstract][Full Text] [Related]
3. Temporal changes in the prevalence of community-acquired antimicrobial-resistant urinary tract infection affected by Escherichia coli clonal group composition.
Smith SP; Manges AR; Riley LW
Clin Infect Dis; 2008 Mar; 46(5):689-95. PubMed ID: 18230040
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for community-acquired urinary tract infection due to quinolone-resistant E. coli.
Colodner R; Kometiani I; Chazan B; Raz R
Infection; 2008 Feb; 36(1):41-5. PubMed ID: 18193386
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for fluoroquinolone-resistant Escherichia coli in adults with community-onset febrile urinary tract infection.
van der Starre WE; van Nieuwkoop C; Paltansing S; van't Wout JW; Groeneveld GH; Becker MJ; Koster T; Wattel-Louis GH; Delfos NM; Ablij HC; Leyten EM; Blom JW; van Dissel JT
J Antimicrob Chemother; 2011 Mar; 66(3):650-6. PubMed ID: 21123286
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases.
Calbo E; Romaní V; Xercavins M; Gómez L; Vidal CG; Quintana S; Vila J; Garau J
J Antimicrob Chemother; 2006 Apr; 57(4):780-3. PubMed ID: 16492721
[TBL] [Abstract][Full Text] [Related]
7. Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.
Rodríguez-Baño J; Alcalá JC; Cisneros JM; Grill F; Oliver A; Horcajada JP; Tórtola T; Mirelis B; Navarro G; Cuenca M; Esteve M; Peña C; Llanos AC; Cantón R; Pascual A
Arch Intern Med; 2008 Sep; 168(17):1897-902. PubMed ID: 18809817
[TBL] [Abstract][Full Text] [Related]
8. Resistance to fluoroquinolones and treatment failure/short-term relapse of community-acquired urinary tract infections caused by Escherichia coli.
Gagliotti C; Buttazzi R; Sforza S; Moro ML;
J Infect; 2008 Sep; 57(3):179-84. PubMed ID: 18707763
[TBL] [Abstract][Full Text] [Related]
9. Dissemination of ST131 and ST393 community-onset, ciprofloxacin-resistant Escherichia coli clones causing urinary tract infections in Korea.
Lee MY; Choi HJ; Choi JY; Song M; Song Y; Kim SW; Chang HH; Jung SI; Kim YS; Ki HK; Son JS; Kwon KT; Heo ST; Yeom JS; Shin SY; Chung DR; Peck KR; Song JH; Ko KS
J Infect; 2010 Feb; 60(2):146-53. PubMed ID: 19932131
[TBL] [Abstract][Full Text] [Related]
10. Increasing antimicrobial resistance in Escherichia coli isolates from community-acquired urinary tract infections during 1998-2003 in Manisa, Turkey.
Kurutepe S; Surucuoglu S; Sezgin C; Gazi H; Gulay M; Ozbakkaloglu B
Jpn J Infect Dis; 2005 Jun; 58(3):159-61. PubMed ID: 15973007
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial resistance in outpatient Escherichia coli urinary isolates in Dakar, Senegal.
Sire JM; Nabeth P; Perrier-Gros-Claude JD; Bahsoun I; Siby T; Macondo EA; Gaye-Diallo A; Guyomard S; Seck A; Breurec S; Garin B
J Infect Dev Ctries; 2007 Dec; 1(3):263-8. PubMed ID: 19734603
[TBL] [Abstract][Full Text] [Related]
12. Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates.
Johnson L; Sabel A; Burman WJ; Everhart RM; Rome M; MacKenzie TD; Rozwadowski J; Mehler PS; Price CS
Am J Med; 2008 Oct; 121(10):876-84. PubMed ID: 18823859
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoin.
Karlowsky JA; Thornsberry C; Jones ME; Sahm DF
Clin Infect Dis; 2003 Jan; 36(2):183-7. PubMed ID: 12522750
[TBL] [Abstract][Full Text] [Related]
14. Nitrofurantoin: the return of an old friend in the wake of growing resistance.
Kashanian J; Hakimian P; Blute M; Wong J; Khanna H; Wise G; Shabsigh R
BJU Int; 2008 Dec; 102(11):1634-7. PubMed ID: 18657135
[TBL] [Abstract][Full Text] [Related]
15. Trimethoprim/sulfamethoxazole resistance in urinary tract infections.
Guneysel O; Onur O; Erdede M; Denizbasi A
J Emerg Med; 2009 May; 36(4):338-41. PubMed ID: 18325714
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic resistance of Escherichia coli from community-acquired urinary tract infections in relation to demographic and clinical data.
Alós JI; Serrano MG; Gómez-Garcés JL; Perianes J
Clin Microbiol Infect; 2005 Mar; 11(3):199-203. PubMed ID: 15715717
[TBL] [Abstract][Full Text] [Related]
17. [E. coli: resistance to quinolones and beta-lactams of clinical strains isolated in the Franche-Comté region of France].
Talon D; Lallemand-De-Conto S; Thouverez M; Bertrand X
Pathol Biol (Paris); 2004 Mar; 52(2):76-81. PubMed ID: 15001235
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for antibiotic-resistant Escherichia coli isolated from hospitalized patients with urinary tract infections: a prospective study.
Sotto A; De Boever CM; Fabbro-Peray P; Gouby A; Sirot D; Jourdan J
J Clin Microbiol; 2001 Feb; 39(2):438-44. PubMed ID: 11158087
[TBL] [Abstract][Full Text] [Related]
19. [Antibiotic resistance among E. coli isolates from urinary tract infections (1999-2000): a multicenter study].
Smaoui H; Mahjoubi F; Boutiba I; Jouaihia W; Thabet L; Znazen A; Kammoun A; Mezghanni S; Triki O; Hammami A; Ben Hassen A; Kechrid A; Ben Redjeb S
Tunis Med; 2003 Jun; 81(6):390-4. PubMed ID: 14534944
[TBL] [Abstract][Full Text] [Related]
20. Escherichia coli from community-acquired urinary tract infections resistant to fluoroquinolones and extended-spectrum beta-lactams.
Kariuki S; Revathi G; Corkill J; Kiiru J; Mwituria J; Mirza N; Hart CA
J Infect Dev Ctries; 2007 Dec; 1(3):257-62. PubMed ID: 19734602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
